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BACKGROUND: Socioeconomic status is associated with differences in risk factors of cardiovascular disease and increased 
risks of cardiovascular disease and mortality. However, it is unclear whether an association exists between cardiovascular 
disease and income, a common measure of socioeconomic status, among patients with hypertension.
METHODS AND RESULTS: This population- based longitudinal study comprised 479 359 patients aged ≥19 years diagnosed 
with essential hypertension. Participants were categorized by income and blood pressure levels. Primary end point was 
all- cause and cardiovascular mortality and secondary end points were cardiovascular events, a composite of cardiovas-
cular death, myocardial infarction, and stroke. Low income was significantly associated with high all- cause (hazard ratio 
[HR], 1.26; 95% CI, 1.23– 1.29, lowest versus highest income) and cardiovascular mortality (HR, 1.31; 95% CI, 1.25– 1.38) 
as well as cardiovascular events (HR, 1.07; 95% CI, 1.05– 1.10) in patients with hypertension after adjusting for age, sex, 
systolic blood pressure, body mass index, smoking status, alcohol consumption, physical activity, fasting glucose, total 
cholesterol, and the use of aspirin or statins. In each blood pressure category, low- income levels were associated with 
high all- cause and cardiovascular mortality and cardiovascular events. The excess risks of all- cause and cardiovascular 
mortality and cardiovascular events associated with uncontrolled blood pressure were more prominent in the lowest in-
come group.
CONCLUSIONS: Low income and uncontrolled blood pressure are associated with increased all- cause and cardiovascular mor-
tality and cardiovascular events in patients with hypertension. These findings suggest that income is an important aspect of 
social determinants of health that has an impact on cardiovascular outcomes in the care of hypertension.
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Socioeconomic status (SES) is an important de-terminant of the likelihood that individuals and populations are exposed to environmental and 
other health risk factors. SES is closely related to car-
diovascular disease (CVD) risk factors, morbidity, and 
mortality.1– 5 Currently, the CVD incidence is the highest 
among individuals with the lowest SES. Low SES is 
linked to the least favorable health behavioral charac-
teristics6– 9 and is also associated with the worst prog-
nosis after cardiac episodes.6– 9 Despite sharp declines 
in CVD mortality during the past 30 years, these bene-
fits have not occurred equally across all populations in 
society. The most striking improvements in cardiovas-
cular health have benefited wealthy, highly educated 
individuals, whereas progress among individuals with 
low SES has lagged, and the gap between high- SES 
and low- SES populations is widening.10
A recent meta- analysis demonstrated an inverse 
association between income as a key indicator of SES 
and CVD and cardiovascular- related deaths.11 However, 
few studies have focused on the relationships among 
income, mortality, and cardiovascular outcomes in pa-
tients with hypertension. Assessing the data from a real- 
world electronic nationwide longitudinal health database 
would not only help better characterize the links among 
income, mortality, and CVD but also help guide efforts to 
reduce CVD burden through health service development 
and primary or secondary prevention. This study was 
conducted to evaluate the effects of income and blood 
pressure (BP) levels and their combined effects on mor-
tality and cardiovascular events in more than 10 years 
of follow- up in 1 554 406 Korean patients with hyper-
tension using a large nationwide representative data set.
METHODS
Data Source
This study involved the analysis of data from the 
National Health Insurance Service (NHIS)– National 
Health examinee database, which includes the data 
of all individuals who underwent National Health 
Examinations sponsored by the NHIS in South Korea. 
NHIS is a single insurance provider in Korea and covers 
97% of the Korean population, whereas the remaining 
3% are covered by the medical aid program. The NHIS 
claims database includes data of demographic char-
acteristics, diagnoses, prescriptions, health screening 
examinations (eg, health questionnaires and laboratory 
tests), and death. Details on the data source have been 
described previously.12 All diagnoses are recorded in 
the NHIS database using International Classification of 
Diseases, Tenth Revision (ICD- 10) codes. The study was 
approved by the Institutional Review Board of Kangbuk 
Samsung Hospital (KBSMC 2019- 12- 022). The NHIS 
provided the anonymized data set to the researchers, 
and the requirement for informed consent was waived.
Study Population
The cohort included 1  554  406 participants aged 
≥19 years who underwent health screening at least twice 
within 4 years between 2002 and 2011. Among these 
participants, we included 612 399 individuals who were 
diagnosed with hypertension (I10– I13) or prescribed an-
tihypertensive medication before the first health screen-
ing examination and had undergone more than 2 health 
examinations within 4 years between 2002 and 2011. We 
excluded patients with a prior diagnosis of myocardial 
infarction (MI; I21– I23) or stroke (I60– I64, I69) (n=62 039) 
and malignancy (C00– C99; n=55  025) or who died 
(n=1079) between the first and last health examinations. 
We also excluded patients with missing values in the 
health examination database (n=14 897). Finally, 479 359 
patients were included in the main analysis. Individuals 
were followed up until death from any cause or the end 
of the study period (December 2017) or were censored 
for the development of MI or stroke (Figure 1).
Sociodemographic Information
As a proxy for income, we used insurance premiums, 
as determined by government assessments of salary 
CLINICAL PERSPECTIVE
What Is New?
• Among individuals with similar blood pressure 
levels, low- income levels were associated with 
high all- cause mortality, cardiovascular mortal-
ity, and cardiovascular event rates.
• Low income and uncontrolled blood pressure 
were associated with increased all- cause mor-
tality, cardiovascular mortality, and cardiovas-
cular events in patients with hypertension.
What Are the Clinical Implications?
• To our knowledge, this is the first study to ex-
amine the combined effects of income and 
blood pressure on all- cause and cardiovascular 
mortality and cardiovascular events in patients 
with hypertension.
• Income is an important aspect of social deter-
minants of health that has an impact on cardio-
vascular outcomes in the care of hypertension.
Nonstandard Abbreviations and Acronyms
NHIS National Health Insurance Service
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and assets. Because health insurance contributions 
in South Korea are imposed proportionally based on 
monthly salary, this measure could reflect income level. 
Household insurance premiums were initially catego-
rized into 20 levels and grouped into quartiles among 
all households in Korea for the index year (Table S1). 
People with very low incomes or special care needs 
are covered by the medical aid program. Medical aid 
beneficiaries do not pay insurance premiums; their 
economic statuses are heterogeneous and are not in-
cluded in income quartiles, and the number of medical 
aid beneficiaries among the screened people was very 
small (0.10%), thus we also excluded these participants.
BP Measurement
BP was measured using either sphygmomanometers 
or oscillometric devices after 3 to 5 minutes of rest at 
health examination centers or clinics. BP was meas-
ured at least twice at 1- minute to 2- minute intervals 
by qualified medical personnel using an appropriately 
sized cuff. The protocol for BP measurement is de-
scribed elsewhere.13 Baseline BP was defined as the 
mean values of 2 BP measurements during different 
health screenings, which we assumed to be represent-
ative of the overall BP levels. The study participants 
were categorized into the following 4 groups according 
to BP: <130/80, 130 to 139/80 to 89, 140 to 149/90 to 
99, ≥150/100 mm Hg.
Follow- Up and Outcome Measurement
Follow- up data obtained for up to 16  years (until 
2018) were analyzed. Median follow- up was 9.2 years 
(interquartile range, 7.0– 11.0). The primary end points 
were all- cause and cardiovascular mortality during the 
study period. The secondary end points were cardio-
vascular events: a composite of cardiovascular death, 
MI, and stroke. All deaths and their causes were re-
trieved from the mortality records of the National 
Statistical Office of Korea. Cardiovascular death 
was defined as death attributed to CVD (I00– I99) 
by certificate. MI was defined as hospitalization with 
ICD- 10 codes I21– I23 as a primary or secondary di-
agnosis. Stroke was defined by discharge diagnosis 
(ICD- 10 codes I60– I69) among patients who had been 
hospitalized.14
Statistical Analysis
Data are reported as mean±SD or median (inter-
quartile range) for continuous variables and as 
number (percentage) for categorical variables. The 
incidence rates were estimated as the total number 
of outcomes during the follow- up period divided by 
100 000 person- years. Cox proportional hazards re-
gression models were used to estimate the effects 
of income and BP level at baseline on the risk of all- 
cause and cardiovascular mortality and cardiovas-
cular events with adjustment for covariates, such as 
age, sex, BP, body mass index, smoking status, al-
cohol consumption, physical activity, fasting glucose, 
total cholesterol, and aspirin or statin use. Covariates 
were carefully selected that were known to affect the 
outcomes.15,16 We evaluated between- group differ-
ences in risk by income/BP strata by visual inspec-
tion of the overlapping of the 95% CI. Subgroup 
analyses by antihypertensive medication use and 
Figure 1. Flowchart of the study population.
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sex were also performed. Statistical analyses were 
performed using SAS version 9.4 (SAS Institute, 
Inc., Cary, NC) and R version 3.6.1 (R Foundation for 
Statistical Computing, Vienna, Austria).
RESULTS
Baseline Characteristics
A total of 479 359 individuals diagnosed with hyper-
tension and with available BP values were followed 
for 4 415 708 person- years. The baseline characteris-
tics by income level are summarized in Table 1. Their 
median age was 60 years (interquartile range, 51– 68 
years), and 57% were women. The age was relatively 
higher in individuals with the highest income, and 
women were more prevalent in the lowest income 
group. BP, alcohol consumption, and body mass index 
were comparable across income levels. The propor-
tions of current smokers were low in the highest in-
come groups. Individuals with low incomes were less 
physically active and more likely to have diabetes mel-
litus and dyslipidemia, whereas individuals with the 
highest income were more likely to take aspirin, statins, 
or antihypertensive medications. These patterns were 
observed regardless of sex, except for a high diabe-
tes mellitus prevalence in women with high incomes 
(Table S2).
Mortality and Cardiovascular Events 
According to Income
Table 2 shows the mortality and cardiovascular event 
rates according to income level. In 4 415 708 person- 
years, 47 860 deaths were observed. The all- cause 
and cardiovascular mortality increased gradually with 
decreasing income. Compared with the highest in-
come group (quartile 1), the lowest group (quartile 4) 
showed a 26% higher risk of all- cause and 31% higher 
cardiovascular mortality after adjusting for sex, age, 
body mass index, smoking, physical activity, comor-
bidity, and aspirin or statin use. Cardiovascular events 
showed a similar trend, with the lowest income group 
showing a 7% higher risk compared with that in the 
highest income group. The risk of MI and stroke were 
also high in individuals with low incomes; however, 
the differences in the risk of these events were not 
prominent across income levels because the absolute 
event rates were low. Subgroup analyses by sex also 
revealed similar results (Table 2).
We further tested whether the associations between 
income and mortality/cardiovascular events differed by 
antihypertensive medication use (Table  3). Similar to 
the main results, mortality and cardiovascular events 
increased gradually with decreasing income, regard-
less of antihypertensive medication use; however, the 
differences in the risk of all- cause and cardiovascular 
mortality and cardiovascular events across income lev-
els were more prominent in those who were not taking 
antihypertensive medications.
Mortality and Cardiovascular Events 
According to Income and BP Levels
The effects of each level of income and BP on mortality 
and cardiovascular events were determined by com-
parison to the lowest BP (<130/80 mm Hg) and highest 
income group. Among individuals with similar BP levels, 
we observed that low income levels were associated 
with the risk of high all- cause and cardiovascular mor-
tality and cardiovascular events (Figure 2, Figure S1A). 
However, in the highest BP (≥150/100 mm Hg) catego-
ries, the risk gradient was slightly attenuated in the low-
est 2 income groups (quartiles 3 and 4), suggesting that 
high BP itself is a powerful risk factor. Of note, individu-
als with the highest income with a BP of 140 to 149/90 
to 99 mm Hg had low all- cause mortality (hazard ratio 
[HR], 1.03; 95% CI, 0.99– 1.08) than those with the low-
est income with a BP of <130/80 mm Hg (HR, 1.20; 
95% CI, 1.14– 1.26). In addition, we explored the risk 
stratified primarily by income and then by BP for each 
income level (Figure 3, Figure S1B). Among individu-
als with similar income levels, we observed that high 
BP was associated with the risk of high all- cause and 
cardiovascular mortality and cardiovascular events. 
Even in the highest income group, the all- cause (HR, 
1.30; 95% CI, 1.24– 1.37) and cardiovascular mortal-
ity (HR, 1.38; 95% CI, 1.26– 1.52) increase significantly 
in the individuals with highest BP (≥150/100 mm Hg). 
Interestingly, J- shaped associations between BP and 
all- cause mortality as well as cardiovascular mortality 
were observed in the group with the highest income, 
with those with a BP of 130 to 139/80 to 89 mm Hg 
showing a lower risk compared with that in those with 
a BP of <130/80 mm Hg. Collectively, low income and 
high BP were associated with a high risk of mortality 
and cardiovascular events.
DISCUSSION
The main findings of this nationwide study were as fol-
lows: (1) patients with hypertension with low incomes 
were not only likely to have unhealthy behaviors but 
also had high risks of all- cause and cardiovascular 
mortality and cardiovascular events, (2) low income 
and high BP had significant effects on all- cause and 
cardiovascular mortality risks and cardiovascular 
events, and (3) the lowest income group had signifi-
cantly more mortality and cardiovascular events com-
pared with those in other income groups, regardless 
of BP. The excess risks of mortality and cardiovascular 
events associated with BP were more prominent in the 
lowest income group.
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Previous studies have assessed the effects of SES 
on CVD and cardiovascular risk factors.1,6,7,17– 21 SES is 
strongly inversely associated with cardiovascular risk 
factors and CVD in high- income and middle- income 
countries. In high- income countries, low income is as-
sociated with a high prevalence of cardiovascular risk 
factors, such as smoking, hypertension, obesity, a 
sedentary lifestyle, diabetes mellitus, and an unhealthy 
Table 1. Baseline Characteristics of the Study Population According to Income Level
Income
P ValueQuartile 1, Highest Quartile 2 Quartile 3
Quartile 4, 
Lowest
Number of patients 163 347 (34.0) 119 253 (24.9) 92 393 (19.3) 104 366 (21.8) <0.0001
Age, y 62 (52– 70) 59 (50– 66) 58 (50– 66) 58 (50– 66) <0.0001
Sex <0.0001
Male 71 570 (43.8) 54 005 (45.3) 41 624 (45.0) 41 176 (39.4)
Female 91 777 (56.2) 65 248 (54.7) 50 769 (55.0) 63 190 (60.6)
Blood pressure, mm Hg <0.0001
Systolic blood pressure 132.4±12.6 132.8±12.9 132.8±13.2 133.1±13.1
Diastolic blood pressure 81.0±7.9 81.6±8.1 81.8±8.2 81.7±8.1
Smoking <0.0001
Never 118 278 (72.4) 82 998 (69.6) 62 740 (67.9) 75 603 (72.4)
Past 26 193 (16.0) 17 656 (14.8) 13 077 (14.2) 12 809 (12.3)
Current 18 876 (11.6) 18 599 (15.6) 16 576 (17.9) 15 954 (15.3)
Physical activity, times/wk <0.0001
0 84 219 (51.5) 64 876 (54.4) 51 456 (55.7) 59 099 (56.6)
1– 2 23 893 (14.6) 17 548 (14.7) 13 882 (15.0) 14 669 (14.0)
3– 4 20 510 (12.6) 13 967 (11.7) 10 224 (11.1) 11 335 (10.9)
5– 6 14 698 (9.0) 9695 (8.1) 7112 (7.7) 8108 (7.8)
7 20 027 (12.3) 13 167 (11.1) 9719 (10.5) 11 155 (10.7)
Alcohol consumption, times/wk <0.0001
0 111 261 (68.1) 77 812 (65.2) 58 754 (63.6) 69 909 (67.0)
<1 18 814 (11.5) 14 681 (12.3) 12 032 (13.0) 12 924 (12.4)
1– 2 21 690 (13.3) 17 351 (14.6) 14 280 (15.5) 14 282 (13.7)
3– 4 6274 (3.8) 5030 (4.2) 3926 (4.2) 3855 (3.7)
≥5 5308 (3.3) 4379 (3.7) 3401 (3.7) 3396 (3.2)
Body mass index, kg/m2 24.8±3.2 25.0±3.3 24.9±3.4 24.8±3.4 <0.0001
<18.5 2636 (1.6) 2004 (1.7) 1686 (1.8) 1973 (1.9)
18.5– 22.9 42 312 (25.9) 30 221 (25.3) 24 308 (26.3) 28 254 (27.1)
23.0– 24.9 42 874 (26.3) 30 032 (25.2) 22 698 (24.6) 26 168 (25.1)
≥25.0 75 525 (46.2) 56 996 (47.8) 43 701 (47.3) 47 971 (45.9)
Fasting serum glucose, mg/dL 105.0±28.4 105.5±30.5 105.6±31.3 105.8±32.3 0.735
<100.0 87 854 (53.8) 64 184 (53.8) 49 984 (54.1) 56 659 (54.3)
100.0– 125.9 54 380 (33.3) 39 166 (32.8) 30 021 (32.5) 33 568 (32.2)
≥126.0 21 113 (12.9) 15 903 (13.4) 12 388 (13.4) 14 139 (13.5)
Total cholesterol, mg/dL 196.3±41.1 197.5±42.9 197.3±40.3 197.7±41.0 <0.0001
<200.0 91 720 (56.2) 65 845 (55.2) 51 318 (55.5) 57 409 (55.0)
200.0– 239.9 51 169 (31.3) 37 458 (31.4) 28 508 (30.9) 32 793 (31.4)
≥240.0 20 458 (12.5) 15 950 (13.4) 12 567 (13.6) 14 164 (13.6)
Diabetes mellitus 18 849 (11.5) 13 397 (11.2) 10 007 (10.8) 11 165 (10.7) <0.0001
Aspirin 43 983 (26.9) 29 557 (24.8) 21 574 (23.4) 25 329 (24.3) <0.0001
Statin 23 293 (14.3) 15 657 (13.1) 11 175 (12.1) 13 034 (12.5) <0.0001
Antihypertensive medication 82 321 (50.4) 58 175 (48.8) 44 535 (48.2) 52 561 (50.4) 0.017
Data are expressed as mean±SD, median (interquartile range), or number (percentage).
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Table 2. Incidence of Mortality and Cardiovascular Events According to Income Level in All Patients With Hypertension
Income
Quartile 1, Highest Quartile 2 Quartile 3 Quartile 4, Lowest
Total
All- cause mortality
Events 17 076 11 010 8812 10 962
Person- years 1 518 195 1 097 667 840 612 959 235
Incidence (events/100 000 person- years) 1125 1003 1048 1143
Adjusted HR (95% CI) Reference 1.12 (1.09– 1.15) 1.22 (1.19– 1.25) 1.26 (1.23– 1.29)
Cardiovascular mortality
Events 4301 2715 2209 2862
Person- years 1 518 195 1 097 667 840 612 959 235
Incidence (events/100 000 person- years) 283 247 263 298
Adjusted HR (95% CI) Reference 1.12 (1.06– 1.17) 1.24 (1.17– 1.30) 1.31 (1.25– 1.38)
MI
Events 3288 2319 1669 2048
Person- years 1 569 652 1 131 642 869 919 997 053
Incidence (events/100 000 person- years) 209 205 192 205
Adjusted HR (95% CI) Reference 1.06 (1.01– 1.12) 1.02 (0.96– 1.08) 1.07 (1.01– 1.13)
Stroke
Events 14 885 9764 7396 8729
Person- years 1 497 688 1 086 012 833 855 954 467
Incidence (events/100 000 person- years) 994 899 887 915
Adjusted HR (95% CI) Reference 1.02 (1.00– 1.05) 1.05 (1.02– 1.07) 1.04 (1.01– 1.06)
Cardiovascular events
Events 20 041 13 262 10 042 12 056
Person- years 1 470 019 1 067 675 819 874 936 690
Incidence (events/100 000 person- years) 1363 1242 1225 1287
Adjusted HR (95% CI) Reference 1.04 (1.02– 1.06) 1.06 (1.03– 1.09) 1.07 (1.05– 1.10)
Men
All- cause mortality
Events 9174 6268 5061 6085
Person- years 687 336 506 781 378 642 374 375
Incidence (events/100 000 person- years) 1335 1237 1337 1625
Adjusted HR (95% CI) Reference 1.13 (1.09– 1.17) 1.25 (1.21– 1.29) 1.28 (1.24– 1.32)
Cardiovascular mortality
Events 2066 1394 1129 1411
Person- years 687 336 506 781 378 642 374 375
Incidence (events/100 000 person- years) 301 275 298 377
Adjusted HR (95% CI) Reference 1.13 (1.05– 1.21) 1.25 (1.16– 1.35) 1.32 (1.23– 1.42)
MI
Events 1847 1351 973 1121
Person- years 715 961 527 122 396 386 396 348
Incidence (events/100 000 person- years) 258 256 245 283
Adjusted HR (95% CI) Reference 1.06 (0.99– 1.14) 1.02 (0.94– 1.10) 1.07 (1.00– 1.16)
Stroke
Events 6711 4583 3409 3958
Person- years 684 862 506 801 380 780 377 989
Incidence (events/100 000 person- years) 980 904 895 1047
 (Continued)
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diet as well as high CVD incidence and mortality.19 A 
recent meta- analysis revealed increased pooled risk 
ratios for low- income versus high- income groups for 
coronary artery disease, cardiovascular events, stroke, 
and cardiovascular- related deaths.11 In another meta- 
analysis, Backholer et al also reported increased 
pooled relative risks in low- income versus high- income 
groups for coronary heart disease, stroke, and all 
CVDs, with no evidence of the differential effect of in-
come by sex.22 However, few studies have assessed 
whether income as an indicator of SES affects mor-
tality and cardiovascular outcomes in patients with 
hypertension. Using a nationwide population- based 
database, our study demonstrated income- related 
excess risks in terms of all- cause mortality, cardiovas-
cular mortality, MI, and stroke among patients with hy-
pertension. These findings were observed regardless 
of antihypertensive medication use or sex. Our study 
also revealed even greater combined effects of BP 
and income on mortality and cardiovascular events. 
In our study, both uncontrolled BP and low income 
were associated with a significantly increased risk of 
all- cause and cardiovascular mortality and cardiovas-
cular events, with synergistic increases in the risks of 
mortality and cardiovascular events if both conditions 
were present.
Several interrelated pathways may explain how in-
come level affects the relationship between hypertension 
Income
Quartile 1, Highest Quartile 2 Quartile 3 Quartile 4, Lowest
Adjusted HR (95% CI) Reference 1.04 (1.00– 1.08) 1.03 (0.99– 1.08) 1.05 (1.01– 1.10)
Cardiovascular events
Events 9483 6545 4910 5758
Person- years 669 098 496 195 372 566 368 083
Incidence (events/100 000 person- years) 1417 1319 1318 1564
Adjusted HR (95% CI) Reference 1.04 (1.01– 1.08) 1.05 (1.01– 1.09) 1.09 (1.05– 1.12)
Women
All- cause mortality
Events 7902 4742 3751 4877
Person- years 830 859 590 886 461 969 584 860
Incidence (events/100 000 person- years) 951 803 812 834
Adjusted HR (95% CI) Reference 1.10 (1.06– 1.14) 1.17 (1.13– 1.22) 1.21 (1.17– 1.26)
Cardiovascular mortality
Events 2235 1321 1080 1451
Person- years 830 859 590 886 461 969 584 860
Incidence (events/100 000 person- years) 269 224 234 248
Adjusted HR (95% CI) Reference 1.10 (1.02– 1.17) 1.20 (1.12– 1.29) 1.28 (1.20– 1.37)
MI
Events 1441 968 696 927
Person- years 853 692 604 520 473 533 600 705
Incidence (events/100 000 person- years) 169 160 147 154
Adjusted HR (95% CI) Reference 1.07 (0.99– 1.16) 1.03 (0.94– 1.13) 1.11 (1.02– 1.21)
Stroke
Events 8174 5181 3987 4771
Person- years 812 826 579 211 453 075 576 478
Incidence (events/100 000 person- years) 1006 894 880 828
Adjusted HR (95% CI) Reference 1.01 (0.98– 1.05) 1.05 (1.01– 1.09) 1.02 (0.98– 1.06)
Cardiovascular events
Events 10 558 6717 5132 6298
Person- years 800 921 571 480 447 308 568 607
Incidence (events/100 000 person- years) 1318 1175 1147 1108
Adjusted HR (95% CI) Reference 1.03 (1.00– 1.07) 1.07 (1.03– 1.10) 1.06 (1.03– 1.10)
HR was adjusted for age, sex, blood pressure level, body mass index, smoking status, alcohol consumption, physical activity, fasting glucose, total 
cholesterol, and aspirin or statin use. HR indicates hazard ratio; and MI, myocardial infarction.
Table 2. Continued
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Figure 2. Mortality and cardiovascular events rates for 16 groups, stratified 
primarily by BP and then by income for each BP level.
A Cox proportional hazard regression model adjusted for age, sex, BP, body mass 
index, smoking status, alcohol consumption, physical activity, fasting glucose, total 
cholesterol, and aspirin or statin use. The x axis refers to HR (95% CI), and HR itself (not 
log [HR]) was plotted. BP indicates blood pressure; and HR, hazard ratio.
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Figure 3. Mortality and cardiovascular events rates for 16 groups, stratified 
primarily by income and then by BP for each income level.
A Cox proportional hazard regression model adjusted for age, sex, BP, body mass 
index, smoking status, alcohol consumption, physical activity, fasting glucose, total 
cholesterol, and aspirin or statin use. The x axis refers to HR (95% CI), and HR itself (not 
log [HR]) was plotted. BP indicates blood pressure; and HR, hazard ratio.
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and mortality or cardiovascular events. First, patients 
with high SES tend to have a high awareness of hyper-
tension prevention and control and better accessibility 
and adherence to medical treatment. We also observed 
that a high income was associated with a high rate of 
administration of antihypertensive medications, aspirin, 
or statins; their preventive effect against cardiovascular 
events may have contributed to the inverse association 
between SES and mortality or cardiovascular events. 
However, income- related adverse outcomes remained 
robust in the group without antihypertensive medication 
use, suggesting an independent role of income level as 
a potent risk factor. Second, the mechanisms driving 
socioeconomic inequalities in CVD are affected by mul-
tiple factors, such as the approachability, acceptability, 
availability, and affordability of medical services.23 A re-
cent systematic review showed an association between 
low SES and reduced access to coronary procedures 
and secondary prevention, which may explain the high 
risk of CVD death among disadvantaged groups.24 We 
observed that the differences in cardiovascular mortal-
ity among income levels were obvious compared with 
those in MI or stroke. Further research is needed to 
evaluate disparities in access to medical care, including 
approachability, availability, accommodation, afford-
ability, and acceptability according to income levels.23 
Third, patients with low SES are more likely to have 
unhealthy lifestyle behaviors and comorbid conditions, 
which lead to increased mortality.25 The current study 
showed that individuals with the highest income were 
more physically active and less likely to have diabetes 
mellitus and dyslipidemia. Moreover, the proportion of 
current smokers was low in the highest income groups. 
Collectively, the mechanism by which low SES con-
tributes to adverse outcomes is complicated by a va-
riety of health behavioral factors, comorbid conditions, 
and out- of- disease factors intertwined with each other, 
which warrants further study.
This study has several strengths. Clinically, it is the 
largest study to demonstrate the effect of income on 
mortality and cardiovascular outcomes in patients with 
hypertension. Our study focused on income as a proxy 
for SES. Despite the relevance of income as a measure 
of socioeconomic factors, the income- related issue 
has received less attention than other SES measures 
or conventional cardiovascular risk factors in most ep-
idemiologic studies, partly because it is sensitive in-
formation. To our knowledge, this is the first study to 
examine the combined effects of income and BP on 
mortality and cardiovascular events in patients with 
hypertension. Moreover, we analyzed a large sample 
of Korean adults, which allowed for comparisons of 
16 groups based on income and BP and analyses of 
all- cause and cardiovascular mortality risks and car-
diovascular events. From a research perspective, our 
study provided evidence to support the associations 
among income, mortality, and cardiovascular events in 
patients with hypertension.
This study has several limitations. First, its retro-
spective design limited the investigation of causal re-
lationships. Second, income level, which was used as 
a proxy for SES, was assessed based on total house-
hold income unadjusted for the number of household 
members because of the lack of information regard-
ing the number of household members, which might 
not assess accurate income level. Furthermore, SES 
is a complex factor comprising several dimensions 
(income, education, employment status, occupational 
position, and neighborhood socioeconomic character-
istics). Thus, our use of a single indicator of SES might 
have underestimated its full effect on mortality and car-
diovascular events. Third, this study included patients 
with hypertension who had undergone at least 2 health 
check- ups to assess the association between mean 
BP outcomes in these patients; however, these may 
not be representative of the entire hypertensive popu-
lation. This cohort tended to include more individuals 
with health concerns and high SES.26 Fourth, because 
this study used ICD- 10 diagnosis codes rather than 
adjudicated events, we cannot rule out diagnostic in-
accuracies for nonfatal cardiovascular events. Fifth, we 
only included cardiovascular death and a new diagno-
sis of MI and stroke as cardiovascular events because 
these are major events that can be used to evaluate the 
long- term prognosis of patients with hypertension and 
can be clearly identified by the ICD code from the NHIS 
data. However, misclassifying or underestimating a di-
agnosis based on the ICD code was still a possibility. 
Finally, this study was based on Korean adults under 
universal health insurance and should be interpreted 
with caution when applied to different populations or 
different healthcare systems.
Perspectives
Income is significantly associated with the risk of all- 
cause mortality, cardiovascular mortality, and car-
diovascular events among patients with hypertension. 
The risks of mortality and cardiovascular events are 
high in those with low incomes and high BP. These 
findings suggest that income is an important aspect 
of social determinants of health that has an impact on 
cardiovascular outcomes in the care of hypertension.
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SUPPLEMENTAL MATERIAL
Table S1. South Korea’s 2018 National Health Insurance Statistics for household insurance premiums by the National Health Insurance Service. 
Premium quintile Number of Households Average premium: won(dollar)/months Number of population 
Sum 24,748,873 101,606 (93.05) 49,562,166 
1st 1,237,443 16,557 (15.16) 1,814,442 
2nd 1,237,443 27,037 (24.76) 1,955,041 
3rd 1,237,444 33,176 (30.38) 1,976,086 
4th 1,237,444 37,291 (34.15) 1,924,347 
5th 1,237,444 38,964 (35.68) 1,935,777 
6th 1,237,443 41,565 (38.06) 1,928,656 
7th 1,237,444 45,693 (41.84) 1,978,637 
8th 1,237,444 50,459 (46.21) 2,032,583 
9th 1,237,443 56,771 (51.99) 2,100,568 
10th 1,237,445 64,946 (59.47) 2,200,270 
11th 1,237,443 73,407 (67.22) 2,260,176 
12th 1,237,443 83,481 (76.45) 2,388,702 
13th 1,237,444 94,238 (86.30) 2,532,407 
14th 1,237,444 106,477 (97.51) 2,651,569 
15th 1,237,444 121,119 (110.91) 2,834,906 
16th 1,237,443 138,802 (127.11) 3,018,399 
17th 1,237,444 161,051 (147.48) 3,202,745 
18th 1,237,444 190,327 (174.29) 3,480,502 
 19th 1,237,443 232,961 (213.33) 3,641,281 




Table S2. Baseline characteristics of the study population according to income level, stratified by sex. 
 Men           Women    
Income Q1, highest Q2 Q3 Q4 P value Q1, highest Q2 Q3 Q4 P value 
Number of patients (%) 71570 (34.3) 54005 (25.9) 41624 (20.0) 41176 (21.8) <0.0001 91777 (44.0) 65248 (31.3) 50769 (24.4) 63190 (30.3) <0.0001 
Age (years) 58 (50-68) 56 (46-66) 56 (46-64) 59 (52-66) <0.0001 64 (55-70) 60 (54-68) 58 (52-66) 58 (50-66) <0.0001 
Blood pressure (mmHg)     <0.0001     <0.0001 
  Systolic blood pressure  133.1 ± 12.0 133.8 ± 12.3 134.1 ± 12.6 135.0 ± 12.7  131.9 ± 85.0 131.9 ± 13.2 131.7 ± 13.5 131.8 ± 13.2  
  Diastolic blood pressure 82.3 ± 7.8 82.9 ± 8.0 83.1 ± 8.2 83.1 ± 8.1  80.0 ± 7.9 80.5 ± 8.0 80.7 ± 8.1 80.8 ± 8.0  
Smoking (%)     <0.0001     <0.0001 
  Never 28693 (40.1) 20034 (37.1) 14448 (34.7) 15259 (37.1)  89585 (97.6) 62964 (96.5) 48292 (95.1) 60344 (95.5)  
  Past 25418 (35.5) 16927 (31.3) 12336 (29.6) 12056 (29.3)  775 (0.8) 729 (1.1) 741 (1.5) 753 (1.2)  
  Current 17459 (24.4) 17044 (31.6) 14840 (35.7) 13861 (33.7)  1417 (1.5) 1555 (2.4) 1736 (3.4) 2093 (3.3)  
Physical activity, times/week (%)     <0.0001     <0.0001 
  0 29915 (41.8) 24810 (45.9) 19765 (47.5) 20027 (48.6)  54304 (59.2) 40066 (61.4) 31691 (62.4) 39072 (61.8)  
  1-2 12637 (17.7) 9725 (18.0) 7471 (17.9) 6599 (16.0)  11256 (12.3) 7823 (12.0)  6411 (12.6) 8070 (12.8)  
  3-4 10496 (14.7) 7395 (13.7) 5372 (12.9) 5212 (12.7)  10014 (10.9) 6572 (10.1) 4852 (9.6) 6123 (9.7)  
  5-6 7669 (10.7) 5013 (9.3) 3772 (9.1) 3771 (9.2)  7029 (7.7) 4682 (7.2) 3340 (6.6) 4337 (6.9)  
  7 10853 (15.2) 7062 (13.1) 5244 (12.6) 5567 (13.5)  9174 (10.0) 6105 (9.4) 4475 (8.8) 5588 (8.8)  
Alcohol consumption, times/week (%)     0.128     <0.0001 
  0 28836 (40.3) 20942 (38.8) 16099 (38.7) 17103 (41.5)  82425 (89.8) 56870 (87.2) 42655 (84.0) 52806 (83.6)  
  <1 13172 (18.4) 9870 (18.3) 7494 (18.0) 6842 (16.6)  5642 (6.1) 4811 (7.4) 4538 (8.9) 6082 (9.6)  
  1-2 18969 (26.5) 14679 (27.2) 11601 (27.9) 10934 (26.6)  2721 (3.0) 2672 (4.1) 2679 (5.3) 3348 (5.3)  
  3-4 5824 (8.1) 4602 (8.5) 3477 (8.4) 3379 (8.2)  450 (0.5) 428 (0.7) 449 (0.9) 476 (0.8)  
  ≥5 4769 (6.7) 3912 (7.2) 2953 (7.1) 2918 (7.1)  539 (0.6) 467 (0.7) 448 (0.9) 478 (0.8)  
Body mass index (kg/m2) 24.9 ± 3.0 25.0 ± 3.2 25.0 ± 3.3 24.8 ± 3.2 <0.0001 24.8 ± 3.3 25.0 ± 3.4 25.0 ± 3.5 24.9 ± 3.5 0.001 
  <18.5 1010 (1.4) 833 (1.5) 674 (1.6) 746 (1.8)  1626 (1.8) 1171 (1.8) 1012 (2.0) 1227 (1.9)  
  18.5–22.9 16584 (23.2) 12832 (23.8) 10558 (25.4) 10851 (26.4)  25728 (28.0) 17389 (26.7) 13750 (27.1) 17403 (27.5)  
  23.0–24.9 19703 (27.5) 14246 (26.4) 10728 (25.8) 10792 (26.2)  23171 (25.2) 15786 (24.2) 11970 (23.6) 15376 (24.3)  
  ≥25.0 34273 (47.9) 26094 (48.3) 19664 (47.2) 18787 (45.6)  41252 (44.9) 30902 (47.4) 24037 (47.3) 29184 (46.2)  
Fasting serum glucose (mg/dL) 107.6 ± 30.0 108.0 ± 33.2 108.4 ± 34.6 110.1 ± 36.5 <0.0001 102.9 ± 26.9 103.5 ± 27.9 103.3 ± 28.0 103.1 ± 28.9 0.228 
  <100.0 34458 (48.1) 26644 (49.3) 20477 (49.2) 19592 (47.6)  53396 (58.2) 37540 (57.5) 29507 (58.1) 37067 (58.7)  
  100.0–125.9 26044 (36.4) 19004 (35.2) 14531 (34.9) 14420 (35.0)  28336 (30.9) 20162 (30.9) 15490 (30.5) 19148 (30.3)  
  ≥126.0 11068 (15.5) 8357 (15.5) 6616 (15.9) 7164 (17.4)  10045 (10.9) 7546 (11.6) 5772 (11.4) 6975 (11.0)  
Total cholesterol (mg/dL) 189.8 ± 39.0 191.7 ± 42.1 191.2 ± 38.3 190.6 ± 39.9 0.001 201.3 ± 42.0 202.3 ± 43.1 202.2 ± 41.2 202.3 ± 41.1 <0.0001 
  <200.0 44924 (62.8) 33015 (61.1) 25616 (61.5) 25652 (62.3)  46796 (51.0) 32830 (50.3) 25702 (50.6) 31757 (50.3)  
  200.0–239.9 20239 (28.3) 15594 (28.9) 11747 (28.2) 11538 (28.0)  30930 (33.7) 21864 (33.5) 16761 (33.0) 21255 (33.6)  
  ≥240.0 6407 (9.0) 5396 (10.0) 4261 (10.2) 3986 (9.7)  14051 (15.3) 10554 (16.2) 8306 (16.4) 10178 (16.1)  
Diabetes mellitus (%) 8404 (11.7) 5992 (11.1) 4599 (11.0) 5127 (12.5) 0.020 10445 (11.4) 7405 (11.3) 5408 (10.7) 6038 (9.6) <0.0001 
Aspirin (%) 20624 (28.8) 13804 (25.6) 9931 (23.9) 11029 (26.8) <0.0001 23359 (25.5) 15753 (24.1) 11643 (22.9) 14300 (22.6) <0.0001 
Statin (%) 9205 (12.9) 6302 (11.7) 4446 (10.7) 4774 (11.6) <0.0001 14088 (15.4) 9355 (14.3) 6729 (13.3) 8260 (13.1) <0.0001 
Antihypertensive medication (%) 35143 (49.1) 25543 (47.3) 19792 (47.5) 21253 (51.6) <0.0001 47178 (51.4) 32632 24743 (48.7) 31308 (49.5) <0.0001 
Data are expressed as mean ± standard deviation, median (interquartile range), or number (percentage). 
 
Figure S1. Risk of myocardial infarction and stroke for 16 groups, classified according to income and blood pressure levels. 
 
A Cox proportional hazard regression model adjusted for age, sex, BP, body mass index (BMI), smoking status, alcohol consumption, physical activity, fasting glucose, total cholesterol, and aspirin or statin use. The X-axis refers to HR (95% CI) and HR itself (not log[HR]) was plotted. HR 
indicates hazard ratio. 
 
